company background image
600223 logo

Lushang Freda PharmaceuticalLtd SHSE:600223 Stock Report

Last Price

CN¥7.72

Market Cap

CN¥7.8b

7D

0.9%

1Y

-31.4%

Updated

14 Jun, 2024

Data

Company Financials +

Lushang Freda Pharmaceutical Co.,Ltd.

SHSE:600223 Stock Report

Market Cap: CN¥7.8b

Lushang Freda Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lushang Freda PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥7.72
52 Week HighCN¥11.55
52 Week LowCN¥6.38
Beta1.92
1 Month Change-8.64%
3 Month Change-18.05%
1 Year Change-31.44%
3 Year Change-49.54%
5 Year Change94.95%
Change since IPO-13.33%

Recent News & Updates

Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?

Apr 16
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?

Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations

Mar 28
Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations

Recent updates

Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?

Apr 16
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?

Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations

Mar 28
Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations

Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 04
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)

Feb 27
A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)

Shareholder Returns

600223CN Real EstateCN Market
7D0.9%-1.0%-0.07%
1Y-31.4%-25.4%-15.5%

Return vs Industry: 600223 underperformed the CN Real Estate industry which returned -25.4% over the past year.

Return vs Market: 600223 underperformed the CN Market which returned -15.5% over the past year.

Price Volatility

Is 600223's price volatile compared to industry and market?
600223 volatility
600223 Average Weekly Movement5.8%
Real Estate Industry Average Movement6.9%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 600223's share price has been volatile over the past 3 months.

Volatility Over Time: 600223's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19933,651n/awww.lshzy.com.cn

Lushang Freda Pharmaceutical Co.,Ltd. develops and operates real estate properties in China. The company offers property management services, such as non-owner value-added and community value-added services.

Lushang Freda Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Lushang Freda PharmaceuticalLtd's earnings and revenue compare to its market cap?
600223 fundamental statistics
Market capCN¥7.80b
Earnings (TTM)CN¥233.09m
Revenue (TTM)CN¥4.20b

33.7x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600223 income statement (TTM)
RevenueCN¥4.20b
Cost of RevenueCN¥2.12b
Gross ProfitCN¥2.07b
Other ExpensesCN¥1.84b
EarningsCN¥233.09m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.23
Gross Margin49.39%
Net Profit Margin5.55%
Debt/Equity Ratio13.7%

How did 600223 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

43%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.